Latest News

• share
• favorite_border

Lausanne, Switzerland, 17th December 2012--- A study published today online in The Journal of Experimental Medicine has identified the population of CD4 T cells serving as the major reservoir for HIV infected cells and as the primary cell site for HIV replication and production in infected patients. The study was led by Prof. Giuseppe Pantaleo and Dr. Matthieu Perreau at the Division of Immunology and Allergy and at the Swiss Vaccine Research Institute, Lausanne University Hospital, Lausanne, Switzerland.

• share
• favorite_border

A new initiative, the Collaboration for HIV/AIDS Immunological Therapy (CHAIT), will be announced at the HIV Functional Cure Symposium in Washington DC, preceding the international AIDS conference, the premier gathering for those working in the field of HIV.

• share
• favorite_border

Own Brain Helps Singles Make Better Choices - A scientific test, now called BrainDesire, helps singles make better choices by tapping into their own brain for finding Mr Right or Ms Right.

• share
• favorite_border

A new diagnostic tool allowing quick and reliable identification of patients with active tuberculosis has been developed by a the Lausanne University Hospital (CHUV) –based research team led by Prof. Giuseppe Pantaleo. Published today in the prestigious journal Nature Medicine, this discovery, based on specific profiles of the immune system, will offer clinical benefit to patients and should contribute to the development of effective vaccines against tuberculosis.

• share
• favorite_border

A study published today online in The Journal of Experimental Medicine sheds light on the potential mechanisms responsible for the increased incidence of HIV infection that was observed in the failed STEP HIV vaccine trial in 2007. Through the development of an experimental in vitro model, the study shows that the immune complexes formed by antibodies and the adenovirus vector (the Trojan horse for the delivery of the vaccine) induce a strong activation signal of key cells, i.e. dendritic cells, responsible for the activation of the cellular arm of the immune response including CD4 T-cells, the primary target for HIV.

• share
• favorite_border

Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the TOCCATA (TOuCh+ for CATheter Ablation) clinical study to evaluate the safety of the TactiCath system with enrollment gaining momentum. TOCCATA is a 70 patient European multi-center safety study.

• share
• favorite_border

The life sciences portal, www.lifescience-online.com, which specialises in bio-financial information has launched the most comprehensive job links site (http://jobs.lifescience-online.com) for the pharmaceutical, bio-finance, biotech and healthcare industry worldwide. Over 40'000 jobs from all around the world are listed on the site.

• share
• favorite_border

A third generation of heart valve has successfully completed animal studies to evaluate the in vivo safety, performance, healing and handling characteristics in both the aortic and mitral positions of its heart valve. Leman Cardiovascular ("LCV"), a Swiss biomedical device company, designed the device and tested it in compliance with ISO/FDA standards. Results showed increased performance over other products, less energy loss in blood cardiac throughput and a 100% survival rate at 90 days.

• share
• favorite_border

Lausanne, Switzerland, 3 December 2007-- The Swiss Institute for Vaccine Research will be launched on December 5, 2007, in Lausanne, Switzerland. The new Institute will encompass the principal aspects of vaccine research to fight the three main infectious diseases : HIV/AIDS, tuberculosis and malaria. The Institute will also benefit from ongoing vaccine research in cancer and influenza.

• share
• favorite_border

Swiss company Leman Cardiovascular ("LCV") today announced that, through its US subsidiary Hancock Jaffe Laboratories, it has signed a partnership deal with Cook Medical, based in Bloomington, Indiana. The partnership deal covers product development in the field of tissue engineering and processing for minimally invasive cardiovascular indications and contract manufacturing.

• share
• favorite_border

Endosense, an emerging cardiovascular device company developing the TactiCath, a unique Force Sensor ablation catheter for use in the field of atrial fibrillation, today announced the appointment of Lawrence Kinet as Chairman of the Board. Mr Kinet was previously a Group Managing Director of Smiths Group PLC and President of Smiths Medical, a major supplier of single-use medical devices used during critical and intensive care procedures with worldwide sales of approximately $1.3 billion.

• share
• favorite_border

Swiss company Leman Cardiovascular ("LCV") today announced that it has acquired Hancock Jaffe Laboratories (HJLI), of Irvine, California, for an undisclosed amount. With this acquisition Leman Cardiovascular realizes its first business development objective.

• share
• favorite_border

Two research teams from Geneva and Lausanne have been awarded the Leenaards Foundation Prize for a total value of seven hundred thousand Swiss francs over the next three years to develop their research into how the brain functions.

• share
• favorite_border

Participants at the Second Global Forum on Pharmaceutical Anticounterfeiting in Paris demand increased cooperation at all levels and a framework convention to fight counterfeiting of medicines.

• share
• favorite_border

The second Global Forum on Pharmaceutical AntiCounterfeiting is a unique gathering of all the parties involved in the fight against the pernicious and dangerous problem of counterfeit and substandard medicines.

• share
• favorite_border

The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005.

• share
• favorite_border

The Bertarelli Foundation announced that it has completed the 2004/2005 round of financing of seven research grants, focusing on different aspects of multiple births. The projects are based in research centres in Australia, England, Spain, Sweden and the United States.

• share
• favorite_border

A research group led by Dr Christophe Bonny, Chief Scientific Officer of Xigen S.A., has been granted a prestigious award from Switzerland's Pfizer Research Award Foundation.

• share
• favorite_border

Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease.

• share
• favorite_border

Reconnaissance International, specialist consultancy in corporate strategy and public policies to combat product counterfeiting, is announcing the second Global Forum on Pharmaceutical AntiCounterfeiting.